当前位置: 首页 > 期刊 > 《新医学》 > 20189
编号:13574492
肺动脉高压大鼠肺组织中TGFβ1和IL6的表达水平及意义(4)
http://www.100md.com 2018年9月1日 《新医学》 20189

     [7]王丹姝,方蓮花,杜冠华转化生长因子β1在肺动脉高压中作用的研究进展中国药理学通报,2017,33(6):741744

    [8]雷丰丰,张启菎,万毅新。转化生长因子β1与肺纤维化新医学,2003,34(11):715716

    [9]Li XW, Du J, Hu GY, Hu CP, Li D, Li YJ, Li XH Fluorofenidone attenuates vascular remodeling in hypoxiainduced pulmonary hypertension of ratsCan J Physiol Pharmacol,2014,92(1):5869

    [10]Hagen M, Fagan K, Steudel W, Carr M, Lane K, Rodman DM, West JInteraction of interleukin6 and the BMP pathway in pulmonary smooth muscleAm J Physiol Lung Cell Mol Physiol,2007,292(6):L1473L1479

    [11]HashimotoKataoka T, Hosen N, Sonobe T, Arita Y, Yasui T, Masaki T, Minami M, Inagaki T, Miyagawa S, Sawa Y, Murakami M, Kumanogoh A, YamauchiTakihara K, Okumura M, Kishimoto T, Komuro I, Shirai M, Sakata Y, Nakaoka YInterleukin6/interleukin21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertensionProc Natl Acad Sci U S A,2015,112(20):E2677E2686

    [12]Humbert M, Monti G, Brenot F, Sitbon O, Portier A, GrangeotKeros L, Duroux P, Galanaud P, Simonneau G, Emilie DIncreased interleukin1 and interleukin6 serum concentrations in severe primary pulmonary hypertensionAm J Respir Crit Care Med,1995,151(5):16281631(邓凯 邹勇 廖志新 郑常龙)
上一页1 2 3 4
    濞e洠鍓濇导鍛閸涱剛杩旈柛娆忓€介埀顒€鍠涚槐婵囩▔瀹ュ棛鈧垶骞嬮幇顏呭床濞达絾娲戠粻锝咁嚈妤︽鍞撮柕鍡曠劍鐢綊鎳¢幇顓炵仐闁圭ǹ娲ょ槐鈺呭Υ閸屾稒鐎紒鏃傚Х婢ф寮堕崘銊ф剑濞存粌楠哥敮顐︽媼濡炲墽绋婇柡澶婂暕濮瑰鏁嶅畝鍐仧闁诡喓鍔忛缁樼▔閻戞﹩鍔冮柡鍌氭矗缁楀鈧绮忛~锕傚绩鐠鸿櫣绉垮〒姘☉閵囧洨鈧娉涢崢銈囨嫻瑜版帗顫夐悹鍥︾串缁辨繄鎷犻悜钘変粡濞寸姾鍩栭崹銊╂偨娴e啰妯堥梺顐f皑閻擄繝骞嬮幋婊勭拨闁挎稑鏈崹婊勭椤掍焦鏆柛鎺嶅嵆閳ь剚姘ㄩ悡锟犲触鎼搭垳绀夊ù鍏兼皑閻濇盯宕¢崘鑼闁诡喓鍔庡▓鎴炴媴濠婂啯鎯傚ù鐘插濠€鎵磾閹寸姷褰查柛鎺斿█濞呭酣濡撮敓锟�

   鐎甸偊鍠曟穱濠囧棘閸モ晝褰�  闁稿繗娅曢弫鐐烘儌閻愵剙顎�  閻犲洤瀚鎴﹀礄閻樻彃缍�  闁瑰吋绮庨崒銊╁即閺夋埈妯�